Related Experiment Video

Updated: May 19, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

Depression in the early stages of Huntington disease

Eric A Epping1, Jane S Paulsen

  • 1Department of Psychiatry, University of Iowa Carver College of Medicine, 1-287 MEB, Iowa City, IA 52242, USA.

Neurodegenerative Disease Management
|September 4, 2012
PubMed

Insights

Huntington disease (HD) often includes depression, even before motor symptoms appear. Early identification and treatment of depression in HD patients are crucial due to suicide risks.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Huntington disease (HD) is increasingly recognized beyond motor deficits.
  • Cognitive and psychiatric symptoms, particularly depression, are significant in HD.
  • Depression occurs during both the prodrome and manifest stages of HD.

Purpose of the Study:

  • To review the presentation of depression in early-stage Huntington disease.
  • To discuss current treatment strategies for depression in HD.
  • To provide clinical guidance for managing depression in this population.

Main Methods:

  • Literature review of studies on Huntington disease and depression.
  • Analysis of prevalence and timing of depressive symptoms in HD.
  • Synthesis of treatment approaches for depression in early HD.

Main Results:

  • Depression is a common psychiatric disturbance in Huntington disease.
  • Depressive symptoms can manifest during the prodromal phase, prior to motor symptom onset.
  • Prevalence of depression is highest during stage 2 of manifest HD.

Conclusions:

  • Depression is a key feature of Huntington disease throughout its course.
  • Early recognition and management of depression are vital for patient well-being and suicide prevention.
  • Clinicians require updated guidance for treating depression in early HD stages.

More Related Videos

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...